Baird Medical Investment Holdings (BDMD)
NASDAQ:BDMD
Want to see BDMD full AI Analyst Report?
BDMD Stock Chart & Stats
$1.76
$0.13(1.73%)
At close: 4:00 PM EST
$1.76
$0.13(1.73%)
Day’s Range― - ―
52-Week Range$0.76 - $7.26
Previous Close$7.55
Volume323.07K
Average Volume (3M)238.60K
Market Cap
$52.45M
Enterprise Value$80.18M
Total Cash (Recent Filing)$178.32K
Total Debt (Recent Filing)$19.30M
Price to Earnings (P/E)―
Beta-0.84
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding40,979,380
10 Day Avg. Volume117,298
30 Day Avg. Volume238,602
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.21
Price to Sales (P/S)1.68
P/FCF Ratio-27.26
Enterprise Value/Market Cap1.53
Enterprise Value/Revenue3.56
Enterprise Value/Gross Profit4.25
Enterprise Value/Ebitda-3.31
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet LeverageDebt around 0.62x equity provides a meaningful equity cushion that supports near-term liquidity and borrowing flexibility. For 2–6 months this reduces refinancing urgency, giving management runway to address operating issues before capital markets intervention becomes necessary.
High Gross MarginsSustained high gross margins indicate strong unit economics and potential pricing power in the medical‑devices business. If revenue stabilizes, high gross margins enable margin recovery via fixed‑cost absorption and targeted reinvestment in R&D or sales to restore profitability over the medium term.
Prior Demonstrated ProfitabilityA profitable 2024 shows the core business model can generate positive operating results absent the 2025 shock. This historical profitability implies the decline may be cyclical or fixable (pricing, mix, or one‑offs), supporting a credible path to recovery if management addresses root causes.
Bears Say
Revenue Decline And LossesA near‑30% revenue contraction coupled with a swing to operating losses materially reduces scale economics and increases unit cost exposure. Persistent top‑line weakness undermines long‑term profitability, heightens execution risk, and magnifies the difficulty of restoring sustainable margins.
Weak Cash GenerationMulti‑year negative operating and free cash flow indicate the business cannot self‑fund operations or investments. This forces reliance on external financing, increases dilution or debt risk, and constrains capital allocation, threatening sustainable product development and market competitiveness.
Eroding Equity And ROEDeclining equity and negative ROE erode the company’s capital buffer, increasing leverage ratios and reducing financial flexibility. Continued losses could breach covenants, limit access to credit, or force dilutive financing, making long‑term recovery harder and more costly.
Baird Medical Investment Holdings News
BDMD FAQ
What was Baird Medical Investment Holdings’s price range in the past 12 months?
Baird Medical Investment Holdings lowest stock price was $0.76 and its highest was $7.26 in the past 12 months.
What is Baird Medical Investment Holdings’s market cap?
Baird Medical Investment Holdings’s market cap is $52.45M.
When is Baird Medical Investment Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Baird Medical Investment Holdings’s earnings last quarter?
Currently, no data Available
Is Baird Medical Investment Holdings overvalued?
According to Wall Street analysts Baird Medical Investment Holdings’s price is currently Overvalued.
Does Baird Medical Investment Holdings pay dividends?
Baird Medical Investment Holdings does not currently pay dividends.
What is Baird Medical Investment Holdings’s EPS estimate?
Baird Medical Investment Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Baird Medical Investment Holdings have?
Baird Medical Investment Holdings has 40,979,380 shares outstanding.
What happened to Baird Medical Investment Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Baird Medical Investment Holdings?
Currently, no hedge funds are holding shares in BDMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Baird Medical Investment Holdings Stock Smart Score
Company Description
Baird Medical Investment Holdings
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
Technical Analysis
Ownership Overview
―
Insiders
0.06% Mutual Funds
0.61% Other Institutional Investors
99.33% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---